0:17 Remdesivir approved by the FDA
1:07 The remdesivir timeline
3:21 COVID-19 Vaccine Tracker
5:47 What was the VRBPAC meeting?
7:18 Challenging the FDA
10:02 What are secondary vaccine endpoints?
11:58 Will the vaccine be mandated?
15:12 Vaccine research representation
18:17 When will pediatric patients be assessed?
23:31 The inflection point of vaccine development
31:13 The implication of remdesivir
37:34 Takeaways from VRBPAC meeting
39:23 What is the trial participation commitment?